+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Uranium-230 Market by Application (Industrial Radiography, Radiolabeling, Research), End Use Industry (Defense, Healthcare, Nuclear Power), Purity Grade, Form, Source, Distribution Channel - Global Forecast 2025-2030- Product Image
Uranium-230 Market by Application (Industrial Radiography, Radiolabeling, Research), End Use Industry (Defense, Healthcare, Nuclear Power), Purity Grade, Form, Source, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Uranium-230 Market by Application (Industrial Radiography, Radiolabeling, Research), End Use Industry (Defense, Healthcare, Nuclear Power), Purity Grade, Form, Source, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133113
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unveiling the Strategic Importance of Uranium-230 in Modern Nuclear Medicine and Research for Pioneering Therapeutic Innovations

The growing interest in Uranium-230 emerges from its potent alpha-emitting properties which make it a critical asset in both therapeutic and diagnostic arenas. As research institutions worldwide delve deeper into targeted alpha therapy clinicians are recognizing its potential for precision oncology where localized high-energy emissions can eradicate cancer cells with minimal damage to surrounding tissues. Beyond oncology the isotope’s high specific activity lends itself to advanced industrial radiography enabling non-destructive inspection of aerospace and automotive components with unparalleled resolution. Radiolabeling applications further underscore its versatility as it facilitates the tracing of molecular pathways in cutting-edge drug development projects.

This introduction provides context on how advancements in separation technologies and isotope purification have transformed Uranium-230 from an obscure laboratory curiosity into a cornerstone of modern radiopharmaceutical research. Regulatory bodies have begun to establish frameworks ensuring safe handling transportation and clinical deployment. Meanwhile strategic collaborations between national laboratories and private enterprises are driving scalable production routes. With preclinical studies advancing toward clinical trials the convergence of scientific innovation and manufacturing capability sets the stage for a new era in which Uranium-230’s unique properties can address unmet medical needs and elevate precision diagnostics.

Examining the Emergence of Uranium-230 as a Catalyst for Transformative Shifts in Nuclear Therapies and Radiological Applications Worldwide

Recent years have witnessed a profound evolution in the Uranium-230 landscape driven by breakthroughs in accelerator-based production and enhanced separation methodologies. These technological strides have unlocked opportunities for large-scale manufacture of this rare isotope at purities suitable for clinical applications. Concurrently the pharmaceutical research community has elevated targeted alpha therapy from theoretical promise to tangible clinical potential with early trials demonstrating impressive tumor regression while sparing healthy tissue.

Regulatory reforms have mirrored scientific progress. Agencies are streamlining approval pathways for radiopharmaceuticals incorporating Uranium-230 enabling faster transitions from bench to bedside. The investment community has responded with significant capital flows into specialized production facilities and contract research organizations. Supply chain digitization efforts are further enhancing traceability and compliance across international borders. Taken together these shifts underscore a transformative moment in which Uranium-230 emerges as a catalyst for next-generation cancer treatments and radiological applications. As innovation momentum accelerates stakeholders are poised to redefine standards of care and industrial inspection protocols worldwide.

Analyzing the Far-Reaching Implications of United States Tariffs Introduced in 2025 on the Global Uranium-230 Supply Chain and Trade Dynamics

The introduction of United States tariffs in 2025 has had a cascading effect on the global Uranium-230 ecosystem disrupting established trade corridors and prompting stakeholders to reevaluate sourcing strategies. Manufacturers subject to higher import duties have faced increased production costs which in turn have influenced downstream contract negotiations for research institutions and healthcare providers. Some producers have responded by accelerating development of domestic extraction and purification facilities to ensure greater self-sufficiency and mitigate exposure to cross-border tariffs.

In parallel regional supply hubs in Europe and Asia-Pacific have seized the opportunity to expand capacity filling gaps left by cost-constrained North American operations. Strategic partnerships between regional governments and private enterprises have fostered new ventures aimed at scaling accelerator production capabilities. These adaptations have enhanced resilience by diversifying the supply base and reducing reliance on a single export market. However the evolving tariff landscape continues to introduce complexity into long-term planning prompting organizations to adopt scenario-based supply chain models. Ultimately the 2025 tariffs have catalyzed a realignment of production and distribution channels reshaping the competitive dynamics of Uranium-230.

Gaining In-Depth Segment Insights by Application Purity Grade Source Form and Distribution for a Holistic Understanding of Uranium-230 Market Dynamics

Dissecting the market along multiple dimensions reveals how each segment contributes to overall demand patterns and innovation trajectories. In terms of application industrial radiography serves as an early adopter by leveraging the isotope’s high-energy emissions for precision imaging while the radiolabeling subsegment supports advanced tracer studies essential to drug discovery. Within research the dual focus on preclinical investigations and clinical trials underscores a continuum that bridges laboratory insights with patient-centric outcomes. Targeted alpha therapy is subdivided into breast cancer protocols and prostate cancer regimens reflecting the distinct dosimetric and pharmacokinetic requirements of each indication.

When viewed through the prism of end use industries, defense programs have begun exploring Uranium-230 for detection systems while healthcare settings ranging from hospitals to specialized nuclear medicine clinics and dedicated research laboratories drive clinical and translational applications. Scientific research institutions further advance both preclinical models and human studies. Purity grade distinctions between clinical grade reagent grade and research grade inform regulatory compliance and application suitability. The choice between powder and solution forms dictates formulation pathways while source considerations weigh mining-derived material against recycled isotopes recovered through closed-loop processes. Distribution channels spanning direct sales networks distributors and online platforms ensure that each stakeholder can access the precise material specification required.

Exploring Regional Variations in Uranium-230 Adoption Trends Across the Americas Europe Middle East Africa and Asia-Pacific to Inform Strategic Planning

Evaluating regional dynamics sheds light on strategic opportunities and potential bottlenecks. In the Americas leading academic centers and national laboratories in North America collaborate closely with private sector partners to secure raw materials and expand production infrastructure. Regulatory support coupled with established logistics networks enables efficient distribution to research hospitals and defense facilities.

Across Europe the Middle East and Africa a diverse landscape unfolds. European nations benefit from mature regulatory frameworks and a tradition of radiopharmaceutical excellence while Middle Eastern initiatives invest heavily in clinical trial capacity. Emerging African resource opportunities and international development programs aim to integrate local mining potential with global radiological supply chains fostering socioeconomic growth. A shared emphasis on harmonizing safety and quality standards across the region further bolsters stakeholder confidence.

In Asia-Pacific rapid expansion of healthcare infrastructures in key markets has spurred demand for advanced radiotherapies. Governments and private entities are forging strategic partnerships to localize production and reduce import dependency. Regulatory harmonization efforts among regional bodies are streamlining clinical trial approvals and commercial applications positioning Asia-Pacific as a pivotal hub for future Uranium-230 innovations.

Profiling Leading Stakeholders Driving Innovation and Collaboration across the Uranium-230 Value Chain from Production to Therapeutic Deployment

A cadre of pioneering organizations is shaping the trajectory of Uranium-230 from production to end use. Leading nuclear service providers have invested in specialized cyclotron and accelerator facilities to optimize isotope yields while biotechnology firms focus on developing next-generation radioconjugates for targeted alpha therapy. Academic and national laboratories play a critical role by advancing fundamental research into decay kinetics dosimetry and safety protocols that underpin regulatory approvals. Collaborative consortia are emerging as powerful platforms for sharing best practices enhancing process efficiencies and establishing quality benchmarks across the value chain.

Meanwhile pharmaceutical companies engaged in radiopharmaceutical development are forging alliances with contract manufacturing organizations to secure consistent high-purity supply. Strategic joint ventures have been announced to co-develop clinical-grade formulations tailored to specific oncology indications. On the financing front investment funds specializing in medtech and nuclear applications are channeling capital into promising scale-up projects. As ecosystem players align their capabilities from raw material sourcing through to clinical deployment the stage is set for accelerated commercialization of Uranium-230-based therapies and diagnostic tools.

Strategic Imperatives and Tactical Recommendations for Industry Leaders to Capitalize on Opportunities and Navigate Challenges in the Uranium-230 Sector

Industry participants can capitalize on emergent opportunities by prioritizing integrated supply chain strategies that blend domestic production with strategic imports. Investing in modular accelerator platforms offers flexibility to expand capacity in line with clinical demand and regulatory milestones. Establishing precompetitive consortia will accelerate standardization of quality protocols and foster collective risk sharing for high-cost process development. Organizations should engage proactively with regulatory authorities to shape approval frameworks that reflect the unique characteristics of alpha-emitting isotopes ensuring timely access to advanced therapies.

On the commercial front diversifying revenue models to include service-based offerings such as on-site isotope management consulting can deepen customer relationships. Healthcare providers can enhance adoption by embedding Uranium-230 therapies within multidisciplinary treatment pathways supported by real-world evidence initiatives. Collaborative research partnerships bridging academia industry and patient advocacy groups will strengthen the evidentiary base required for broader reimbursement. Finally deploying advanced analytics to monitor supply chain performance and clinical outcomes will inform iterative refinements boosting both operational efficiency and therapeutic impact.

Detailing the Comprehensive Research Methodology Underpinning the Uranium-230 Market Analysis to Ensure Rigor Transparency and Reliability

Our approach commenced with an extensive survey of publicly available literature spanning peer-reviewed journals conference proceedings regulatory guidelines and patent filings to build a foundational knowledge base. This phase was complemented by proprietary interviews with subject matter experts including radiopharmaceutical scientists production engineers and regulatory advisors ensuring multidimensional perspectives. Data gathered from primary sources such as facility walkthroughs and operational audits were triangulated against secondary research for validation.

We further segmented analysis by application end use industry purity grade form source and distribution channel to capture nuanced demand drivers and supply constraints. Regional examinations incorporated economic indicators healthcare infrastructure metrics and policy reviews to contextualize adoption patterns across the Americas Europe the Middle East Africa and Asia-Pacific. Quality control measures included cross-referencing expert inputs with historical trend data and scenario stress testing of geopolitical and regulatory shifts. The result is a robust and transparent methodology that underpins every insight presented in this report.

Concluding Insights on the Critical Role of Uranium-230 in Shaping Future Radiopharmaceutical Innovations and Strategic Directions for Stakeholders

In conclusion Uranium-230 stands at the intersection of scientific innovation market opportunity and strategic realignment. Advances in production technologies regulatory harmonization and therapeutic applications are coalescing to transform this niche isotope into a cornerstone of precision oncology diagnostics and industrial inspection. The cumulative impact of tariff adjustments has underscored the importance of supply chain resilience while segmentation and regional insights reveal a complex tapestry of demand patterns shaped by clinical needs and policy landscapes.

Key stakeholders from nuclear service providers to pharmaceutical developers and academic institutions are forging collaborative ecosystems that span basic research through clinical deployment. Actionable pathways exist for industry leaders to solidify competitive advantage by investing in modular capacity forging precompetitive alliances and leveraging real-world data. As the market matures concerted efforts to harmonize quality standards and accelerate clinical trial progression will be vital. Ultimately the strategic importance of Uranium-230 will be measured by its ability to deliver life-changing therapies and enhance industrial capabilities worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Industrial Radiography
    • Radiolabeling
    • Research
      • Clinical Trials
      • Preclinical Research
    • Targeted Alpha Therapy
      • Breast Cancer
      • Prostate Cancer
  • End Use Industry
    • Defense
    • Healthcare
      • Hospitals
      • Nuclear Medicine Clinics
      • Research Labs
    • Nuclear Power
    • Scientific Research
      • Clinical Trials
      • Preclinical Research
  • Purity Grade
    • Clinical Grade
    • Reagent Grade
    • Research Grade
  • Form
    • Powder
    • Solution
  • Source
    • Mining
    • Recycled
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Joint Stock Company National Atomic Company Kazatomprom
  • Cameco Corporation
  • Orano SA
  • Uranium One Inc.
  • China National Nuclear Corporation
  • BHP Group Limited
  • Rio Tinto plc
  • Energy Fuels Inc.
  • NexGen Energy Ltd.
  • Paladin Energy Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of uranium-230 isotopic enrichment technologies for advanced nuclear reactors
5.2. Expansion of strategic stockpiling initiatives for uranium-230 to secure long term energy supply
5.3. Innovative separation methodologies improving uranium-230 purity levels for medical isotope applications
5.4. Rising collaboration between government agencies and private sector for uranium-230 research funding
5.5. Increasing regulatory scrutiny on uranium-230 handling and transportation impacting market dynamics
5.6. Development of modular microreactor designs optimized for uranium-230 fuel utilization in remote regions
5.7. Technological advancements in laser isotope separation driving cost reduction for uranium-230 production
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Uranium-230 Market, by Application
8.1. Introduction
8.2. Industrial Radiography
8.3. Radiolabeling
8.4. Research
8.4.1. Clinical Trials
8.4.2. Preclinical Research
8.5. Targeted Alpha Therapy
8.5.1. Breast Cancer
8.5.2. Prostate Cancer
9. Uranium-230 Market, by End Use Industry
9.1. Introduction
9.2. Defense
9.3. Healthcare
9.3.1. Hospitals
9.3.2. Nuclear Medicine Clinics
9.3.3. Research Labs
9.4. Nuclear Power
9.5. Scientific Research
9.5.1. Clinical Trials
9.5.2. Preclinical Research
10. Uranium-230 Market, by Purity Grade
10.1. Introduction
10.2. Clinical Grade
10.3. Reagent Grade
10.4. Research Grade
11. Uranium-230 Market, by Form
11.1. Introduction
11.2. Powder
11.3. Solution
12. Uranium-230 Market, by Source
12.1. Introduction
12.2. Mining
12.3. Recycled
13. Uranium-230 Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. Online
14. Americas Uranium-230 Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Uranium-230 Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Uranium-230 Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Joint Stock Company National Atomic Company Kazatomprom
17.3.2. Cameco Corporation
17.3.3. Orano SA
17.3.4. Uranium One Inc.
17.3.5. China National Nuclear Corporation
17.3.6. BHP Group Limited
17.3.7. Rio Tinto plc
17.3.8. Energy Fuels Inc.
17.3.9. NexGen Energy Ltd.
17.3.10. Paladin Energy Ltd.
18. ResearchAI19. ResearchStatistics20. ResearchContacts21. ResearchArticles22. Appendix
List of Figures
FIGURE 1. URANIUM-230 MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL URANIUM-230 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL URANIUM-230 MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL URANIUM-230 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL URANIUM-230 MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL URANIUM-230 MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URANIUM-230 MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL URANIUM-230 MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL URANIUM-230 MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL URANIUM-230 MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS URANIUM-230 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS URANIUM-230 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES URANIUM-230 MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES URANIUM-230 MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC URANIUM-230 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC URANIUM-230 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. URANIUM-230 MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. URANIUM-230 MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. URANIUM-230 MARKET: RESEARCHAI
FIGURE 28. URANIUM-230 MARKET: RESEARCHSTATISTICS
FIGURE 29. URANIUM-230 MARKET: RESEARCHCONTACTS
FIGURE 30. URANIUM-230 MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. URANIUM-230 MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL URANIUM-230 MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL URANIUM-230 MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL URANIUM-230 MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL URANIUM-230 MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL URANIUM-230 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL URANIUM-230 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL URANIUM-230 MARKET SIZE, BY INDUSTRIAL RADIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL URANIUM-230 MARKET SIZE, BY INDUSTRIAL RADIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL URANIUM-230 MARKET SIZE, BY RADIOLABELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL URANIUM-230 MARKET SIZE, BY RADIOLABELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL URANIUM-230 MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL URANIUM-230 MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL URANIUM-230 MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL URANIUM-230 MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL URANIUM-230 MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL URANIUM-230 MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL URANIUM-230 MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL URANIUM-230 MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL URANIUM-230 MARKET SIZE, BY DEFENSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL URANIUM-230 MARKET SIZE, BY DEFENSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL URANIUM-230 MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL URANIUM-230 MARKET SIZE, BY HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL URANIUM-230 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL URANIUM-230 MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL URANIUM-230 MARKET SIZE, BY NUCLEAR MEDICINE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL URANIUM-230 MARKET SIZE, BY NUCLEAR MEDICINE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL URANIUM-230 MARKET SIZE, BY NUCLEAR POWER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL URANIUM-230 MARKET SIZE, BY NUCLEAR POWER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL URANIUM-230 MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL URANIUM-230 MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL URANIUM-230 MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL URANIUM-230 MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL URANIUM-230 MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL URANIUM-230 MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL URANIUM-230 MARKET SIZE, BY REAGENT GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL URANIUM-230 MARKET SIZE, BY REAGENT GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL URANIUM-230 MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL URANIUM-230 MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL URANIUM-230 MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL URANIUM-230 MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL URANIUM-230 MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL URANIUM-230 MARKET SIZE, BY MINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL URANIUM-230 MARKET SIZE, BY MINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL URANIUM-230 MARKET SIZE, BY RECYCLED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL URANIUM-230 MARKET SIZE, BY RECYCLED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL URANIUM-230 MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL URANIUM-230 MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL URANIUM-230 MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL URANIUM-230 MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL URANIUM-230 MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL URANIUM-230 MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS URANIUM-230 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS URANIUM-230 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES URANIUM-230 MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES URANIUM-230 MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 130. CANADA URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 131. CANADA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 132. CANADA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 133. CANADA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 134. CANADA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 135. CANADA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 136. CANADA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 137. CANADA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 138. CANADA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 139. CANADA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 140. CANADA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 141. CANADA URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 142. CANADA URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 143. CANADA URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 144. CANADA URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 145. CANADA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 150. MEXICO URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 151. MEXICO URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 158. MEXICO URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 159. MEXICO URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 162. MEXICO URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 163. MEXICO URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA URANIUM-230 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 252. GERMANY URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 253. GERMANY URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 256. GERMANY URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 260. GERMANY URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 261. GERMANY URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 264. GERMANY URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 265. GERMANY URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. GERMANY URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. FRANCE URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 272. FRANCE URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 273. FRANCE URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 274. FRANCE URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 275. FRANCE URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 276. FRANCE URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 277. FRANCE URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 278. FRANCE URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 279. FRANCE URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 280. FRANCE URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 281. FRANCE URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 283. FRANCE URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 284. FRANCE URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 285. FRANCE URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 286. FRANCE URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 287. FRANCE URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. FRANCE URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. ITALY URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. ITALY URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. ITALY URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 312. ITALY URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 313. ITALY URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 314. ITALY URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 315. ITALY URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 316. ITALY URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 317. ITALY URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 318. ITALY URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 319. ITALY URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 320. ITALY URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 321. ITALY URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 322. ITALY URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 323. ITALY URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 324. ITALY URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 325. ITALY URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 326. ITALY URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 327. ITALY URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. ITALY URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. SPAIN URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. SPAIN URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. SPAIN URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 332. SPAIN URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 333. SPAIN URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 334. SPAIN URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 335. SPAIN URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 336. SPAIN URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 337. SPAIN URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 338. SPAIN URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 339. SPAIN URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 340. SPAIN URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 341. SPAIN URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 342. SPAIN URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 343. SPAIN URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 344. SPAIN URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 345. SPAIN URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 346. SPAIN URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 347. SPAIN URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 348. SPAIN URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2018-2024 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY TARGETED ALPHA THERAPY, 2025-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY SCIENTIFIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 368. UNITED ARAB EMIRATES URANIUM-230 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 369. SAUDI ARABIA URANIUM-230 MARKET SIZ

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Uranium-230 Market report include:
  • Joint Stock Company National Atomic Company Kazatomprom
  • Cameco Corporation
  • Orano SA
  • Uranium One Inc.
  • China National Nuclear Corporation
  • BHP Group Limited
  • Rio Tinto plc
  • Energy Fuels Inc.
  • NexGen Energy Ltd.
  • Paladin Energy Ltd.

Related Reports

Uranium-233 Market by End Use (Industrial Applications, Medicine, Power Generation), Source Type (Breeding, Enrichment, Reprocessing), Purity Grade, Supply Mode - Global Forecast 2025-2030 - Product Image

Uranium-233 Market by End Use (Industrial Applications, Medicine, Power Generation), Source Type (Breeding, Enrichment, Reprocessing), Purity Grade, Supply Mode - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Uranium Tetrafluoride Market by End Use Industry (Defense, Medical, Nuclear Power), Purity (Nuclear Grade, Technical Grade), Physical Form, Production Process, Application - Global Forecast 2025-2030 - Product Image

Uranium Tetrafluoride Market by End Use Industry (Defense, Medical, Nuclear Power), Purity (Nuclear Grade, Technical Grade), Physical Form, Production Process, Application - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Uranium Tetrafluoride Powder Market by Application (Chemical Industry, Laboratory Use, Metal Production), Purity Grade (Nuclear Grade, Technical Grade), Source, End-User, Production Process - Global Forecast 2025-2030 - Product Image

Uranium Tetrafluoride Powder Market by Application (Chemical Industry, Laboratory Use, Metal Production), Purity Grade (Nuclear Grade, Technical Grade), Source, End-User, Production Process - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
In-Situ Leach Mining of Uranium Market by End Use (Industrial Applications, Medical Isotopes, Nuclear Energy), Leach Solution Type (Acidic Solution, Alkaline Solution), Well Pattern, Project Scale, Ownership Type - Global Forecast 2025-2030 - Product Image

In-Situ Leach Mining of Uranium Market by End Use (Industrial Applications, Medical Isotopes, Nuclear Energy), Leach Solution Type (Acidic Solution, Alkaline Solution), Well Pattern, Project Scale, Ownership Type - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Uranium Enrichment & Uranium Conversion Market by Service Type (Conversion Service, Enrichment Service), Application (Defense Research, Naval Propulsion Fuel, Nuclear Power Fuel) - Global Forecast 2025-2030 - Product Image

Uranium Enrichment & Uranium Conversion Market by Service Type (Conversion Service, Enrichment Service), Application (Defense Research, Naval Propulsion Fuel, Nuclear Power Fuel) - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.